Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review

被引:50
|
作者
Guo, Jingbo [1 ]
Shao, Jie [1 ]
Yang, Yuan [2 ]
Niu, Xiaodan [1 ]
Liao, Juan [1 ]
Zhao, Qing [1 ]
Wang, Donghui [1 ]
Li, Shuaitong [1 ]
Hu, Junping [1 ,2 ]
机构
[1] Lanzhou Univ, Sch Nursing, Lanzhou, Peoples R China
[2] Lanzhou Univ, Reprod Med Special Hosp, Key Lab Reprod Med & Embryo, Hosp 1, Lanzhou, Peoples R China
关键词
Microbiota; Polycystic ovary syndrome; Comparison; Dysbiosis; Systematic review; INSULIN-RESISTANCE; SYNDROME PCOS; WOMEN; INFLAMMATION; OBESITY; HEALTH; EXPRESSION; PARAMETERS; DYSBIOSIS; WEIGHT;
D O I
10.1007/s43032-020-00430-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary Syndrome (PCOS) is one of the most popular diseases that cause menstrual dysfunction and infertility in women. Recently, the relationships between the gastrointestinal microbiome and metabolic disorders such as obesity, type 2 diabetes and PCOS have been discovered. However, the association between the gut microbiome and PCOS symptoms has not been well established. We systematically reviewed existing studies comparing gut microbial composition in PCOS and healthy volunteers to explore evidence for this association. A systematic search was carried out in PubMed, Embase, Cochrane Library, and Web of Science from inception to May 26, 2020, for all original cross-sectional, cohort, or case-control studies comparing the fecal microbiomes of patients with PCOS with microbiomes of healthy volunteers (controls). The primary outcomes were differences in specific gut microbes between patients with PCOS and controls. The search identified 256 citations; 10 studies were included. The total population study of these articles consists of 611 participants (including PCOS group and healthy controls group). Among the included 10 studies, nine studies compared alpha-diversity, and six studies demonstrated that alpha-diversity has a significant reduction in PCOS patients. Seven of them reported that there was a significant difference of beta-diversity composition between healthy controls groups and PCOS patients. The most common bacterial alterations in PCOS patients included Bacteroidaceae, Coprococcus, Bacteroides, Prevotella, Lactobacillus, Parabacteroides, Escherichia/Shigella, and Faecalibacterium prausnitzii. No consensus has emerged from existing human studies of PCOS and gut microbiome concerning which bacterial taxa are most relevant to it. In this systematic review, we identified specific bacteria associated with microbiomes of patients with PCOS vs controls. Higher level of evidence is needed to determine whether these microbes are a product or cause of PCOS.
引用
收藏
页码:69 / 83
页数:15
相关论文
共 50 条
  • [41] Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments
    Garcia-Beltran, Cristina
    Malpique, Rita
    Carbonetto, Belen
    Gonzalez-Torres, Pedro
    Henares, Desiree
    Brotons, Pedro
    Munoz-Almagro, Carmen
    Lopez-Bermejo, Abel
    de Zegher, Francis
    Ibanez, Lourdes
    PEDIATRIC OBESITY, 2021, 16 (04):
  • [42] Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
    Zhou, Ling
    Ni, Zhexin
    Yu, Jin
    Cheng, Wen
    Cai, Zailong
    Yu, Chaoqin
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [43] Exercise therapy in polycystic ovary syndrome: a systematic review
    Harrison, Cheryce L.
    Lombard, Catherine B.
    Moran, Lisa J.
    Teede, Helena J.
    HUMAN REPRODUCTION UPDATE, 2011, 17 (02) : 171 - 183
  • [44] The Role of Oxytocin in Polycystic Ovary Syndrome: A Systematic Review
    Cera, Nicoletta
    Pinto, Joana
    Pignatelli, Duarte
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (06) : 5223 - 5241
  • [45] Phthalates and polycystic ovary syndrome - Systematic literature review
    Neuvonen, Roosa
    Huovinen, Marjo
    Dorman, David C.
    Laitinen, Heikki
    Sahlman, Heidi
    REPRODUCTIVE TOXICOLOGY, 2023, 121
  • [46] Bisphenol A and polycystic ovary syndrome in human: A systematic review
    Urbanetz, Lorena Ana Mercedes Lara
    Soares-Junior, Jose Maria
    Simoes, Ricardo dos Santos
    Maciel, Gustavo Arantes Rosa
    Baracat, Maria Candida Pinheiro
    Baracat, Edmund Chada
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (01) : 190 - 203
  • [47] The role of metformin in polycystic ovary syndrome: a systematic review
    Moll, Etelka
    van der Veen, Fulco
    van Wely, Madelon
    HUMAN REPRODUCTION UPDATE, 2007, 13 (06) : 527 - 537
  • [48] Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature
    Menichini, Daniela
    Ughetti, Claudia
    Monari, Francesca
    Di Vinci, Pier Luigi
    Neri, Isabella
    Facchinetti, Fabio
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (08) : 623 - 631
  • [49] Meta-analysis of gut microbiota biodiversity in patients with polycystic ovary syndrome based on medical images
    Wang, Baimiao
    Hu, Lanyawen
    Dong, Panpan
    SLAS TECHNOLOGY, 2024, 29 (04):
  • [50] A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome
    Costello, MF
    Eden, JA
    FERTILITY AND STERILITY, 2003, 79 (01) : 1 - 13